|
Market Cap (5-Jul) $1,667,200 (1,583rd) |
Close (30-Jun) $0.003 |
Volume (30-Jun) 21,427 |
Shortsold (14-Feb) 10,000,000 (0.20%) (406th) |
|
52w High $0.020 |
52w Low $0.004 |
P/E - |
EPS -0.04 |
ADR released this announcement to the ASX on 5 August 2022, 14:28. The announcement is not marked as price sensitive, and is 1 page(s) in length and 246.08kb in size.
You can view all announcements from ADR and see how they appear on a price chart on the announcements page.
At the date of this announcement, ADR was 0.200% short sold according to ASIC data. It was ranked the 406th most shorted stock on the ASX. It remains ranked 406th as of the latest reported data (14 February 2023).
| Other Recent Announcements from ADR | |
|---|---|
| Application for quotation of securities - ADR | 28 June 2023, 16:25 |
| Change of Auditor | 27 June 2023, 9:41 |
| Notification of cessation of securities - ADR | 11 May 2023, 13:49 |
| Details of Company Address - Principal Administrative Office | 5 August 2022, 14:28 |
| Adherium submits US FDA application for Hailie for GSK pMDIs | 2 August 2022, 10:22 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 July 2022, 10:00 |
| Adherium receives US FDA clearance for Hailie for Ellipta | 25 July 2022, 12:08 |
You must be logged in to post a reply.
Adherium 